Determining the Impact of the Interactions of CYP2B6*6 and CYP2A6 Polymorphisms on the Treatment of Nicotine Dependence

Introduction: Nicotine metabolising enzymes CYP2B6 and CYP2A6 have been linked to nicotine addiction treatment. Despite evidence that they may interact to influence nicotine dependence treatment outcomes in terms of nicotine dependence and withdrawal syndromes, as well as therapy kinds (placebo, bupropion, and NRT), their role in nicotine cessation has yet to be thoroughly proven and…
Read more


September 15, 2021 0